title: Treatment patterns and symptom control in patients with GERD: US community-based survey.
abstract: BACKGROUND
  Proton pump inhibitors (PPIs) are the most commonly used pharmacological treatment for gastroesophageal reflux disease (GERD).
  
  
  OBJECTIVE
  To examine the utilization patterns of PPIs and other GERD-related medications, satisfaction with PPI treatment and presence of GERD symptoms.
  
  
  METHODS
  GERD patients using prescription PPIs were identified from a mixed-model HMO health plan. Utilization patterns of PPIs and other GERD medications, satisfaction with PPI treatment and presence of GERD symptoms were assessed using questionnaires.
  
  
  RESULTS
  Among the 617 patients who completed the survey, 71.0% used PPIs once a day (QD), 22.2% used twice a day (BID) and 6.8% more than twice a day or on an as-needed basis. Approximately 42.1% of all patients supplemented their prescription PPIs with other GERD medications, including over-the-counter medications and H(2)-receptor antagonists. Over 85% of the patients still experienced GERD symptoms and 82.7% nighttime symptoms. Overall, 72.8% of all patients were satisfied or very satisfied with their PPI treatment.
  
  
  CONCLUSIONS
  The study used self-reported data which may have been subject to recall bias. As the study was conducted in a specific region of the US, the results may have limited generalizability to other US regions or countries.
  
  
  CONCLUSIONS
  Patients on PPI treatment often experience GERD symptoms and supplement their prescription PPIs with other GERD medications. A substantial proportion of GERD patients receiving PPI treatment are on a BID regimen. Furthermore, more than a quarter of the patients are not completely satisfied with their PPI treatment.
authors.affiliation: University of Michigan Health System, Ann Arbor, MI 48109-0362, USA. wchey@umich.edu
authors.forename: William D
authors.initials: WD
authors.lastname: Chey
authors.forename: Reema R
authors.initials: RR
authors.lastname: Mody
authors.forename: Eric Q
authors.initials: EQ
authors.lastname: Wu
authors.forename: Lei
authors.initials: L
authors.lastname: Chen
authors.forename: Smita
authors.initials: S
authors.lastname: Kothari
authors.forename: Bjorn
authors.initials: B
authors.lastname: Persson
authors.forename: Nicolas
authors.initials: N
authors.lastname: Beaulieu
authors.forename: Mei
authors.initials: M
authors.lastname: Lu
mesh_terms: D000368:Aged; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000503:physiopathology*; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D008404:Massachusetts; D008875:Middle Aged; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D054328:Proton Pump Inhibitors / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011795:Surveys and Questionnaires; D014481:United States
chemical_list: D054328:Proton Pump Inhibitors